While a reduction in testosterone, DHT, and/or AR signaling has been associated with abdominal obesity, hyperglycemia, insulin resistance, leptin resistance, metabolic syndrome, and type 2 diabetes in males, it has been related to an improved metabolic phenotype in females (164, 172, 181–184). Here, AR is linked to metabolic syndrome.